IL33 and amyloidosis: IL-33 promotes homeostatic synaptic plasticity, reduces amyloid plaque deposition, increases microglial phagocytosis of amyloid, improves amyloid-induced behavioral deficits, and is neuroprotective in stroke models [68, 70, 71].